Search results for biopharmaceutical

Turkey’s biotech manufacturing ambitions: Yerlika Biopharma’s strategic role

Abstract: Yerlika Biopharma is a pioneering biotechnology company in Turkey. Company CEO, Hasan Zeytin MD, PhD spoke to GaBI (Generics and Biosimilars Initiative) about the company’s strategic focus, Yerlika is dedicated to reducing the country’s dependency on imported biological products through localizing biopharmaceutical production in Turkey. With state-of-the-art manufacturing facilities the company also aims to […]

Read more →

Comment on ‘Misinformation about interchangeable biosimilars’

Author byline as per print journal: Hillel P Cohen, PhD; Caridad Pontes, MD, PhD; Fernando de Mora, MBA, PhD Abstract: The critique of Reilly and McKibben of the meta-analysis conducted by Herndon et al. is factually flawed on several important points. As a result, the conclusions of Reilly and McKibben are not scientifically substantiated. Submitted: […]

Read more →

Biologicals and biosimilars: a review of the science and its implications

Abstract: Biopharmaceuticals are medicines whose active drug substance is made by living cells. Copies of these drugs, called biosimilars, are not identical to their reference drug and therefore specific regulatory requirements for registration apply. Whereas pharmaceutical quality evaluation requires a full dossier and a detailed comparative analysis to the reference drug, non-clinical and clinical requirements […]

Read more →